Dreiling/Schmidt
Cancer Institute
785-623-5774
2220 Canterbury Drive
Hays, KS 67601 | Directions
Annual Report Review of Data
2014 Highlights
Patient Care Enhancements
*Cancer Institute expansion completed and re-opens for patient care in January
*HaysMed Foundation begins campaign to bring TrueBeam® Linear Accelerator to the Radiation Oncology Department
*Full time Medical Physicist begins employment in Radiation Oncology Department
Accreditation Changes
*Medical Oncology receives American Society of Clinical Oncology Quality Oncology Practice Initiative (QOPI) Certification
*Radiation Oncology department receives American College of Radiation Oncology (ACRO) Accreditation
Partnerships
*Continued partnership with the Midwest Cancer Alliance (MCA) at the University of Kansas Medical Center, which continues to enrich our program by providing professional education and access to clinical research trials and studies
Community Education, Screenings, and Activities
*Staff attends annual MCA Meeting
*Annual Spring Cancer Symposium held @ HaysMed
*Monthly Programs: “Look Good, Feel Better”, Cancer Support Groups
*Center for Health Improvement programs: “Healing in Motion”, Lymphedema Therapy
*American Cancer Society Programs: wig bank, transportation assistance, Relay for Life, personal health managers
*Pink Flamingo events to promote Breast Cancer Awareness during October
2014 Stats
Medical Oncology
During 2014, there were a total of 10426 patient visits (40% males and 60% females); this number includes those patients seen by the providers in clinic visits. There were 49 patients seen for colon cancer (53% males, 47% females); 113 patients seen for lung cancer (53% males, 47% females); 475 patients for breast cancer (0.2% males, 99.8% females); 42 patients for prostate cancer (100% males); 95 patients for lymphoma (52% males, 48% females); and 1638 patients for other diagnoses (42% males, 58% females).
Radiation Oncology
In 2014, 231 patients were treated; 200 were new patients and 31 had previously been treated. There were an additional 45 patients seen for consultation only. 250 total courses of radiation therapy were delivered. There were 104 (45%) males and 127 (55%) females who received treatments. 69 women (30% of patients for the year) were treated for breast cancer, 22 (10%) men were treated for prostate cancer, 37 (16%) patients were treated for lung cancer, 21 (9%) patients were treated for skin cancer, and 13 (6%) patients were treated for colo/rectal cancer. 397 (phone 332, onsite 65) follow-up visits occurred.
Inpatient Oncology
The Inpatient Oncology Unit had 278 admissions during 2014 which resulted in 1753 patient days. The average length of stay was 6.3 days. Of the 278 admissions, 50.2% were males and 49.8% were females. Patient admissions included but were not limited to treatment for disease management, pain control, radiation implant management, and chemotherapy administration. Patients with Lung cancer (15%) was the largest single diagnosis group. Other significant diagnoses included Liver, stomach, esophagus, kidney and pancreatic cancers made up (9%). Leukemia and Colon each were at (8%) and Lymphoma was at (7%). Six percent of the patients were treated for breast and bone cancer. Brain Cancer made up (3%) . Ovarian, skin and oral cancers made up (1%) each of the patients and the remaining 34% of admissions were for other, non-specific diagnoses including blood, benign, and unrelated diagnoses
2014 Comparison of Major Site Distributions Reported by HaysMed for last Five Years
Comparison of 2014 Major Site Distributions of National/State Estimations* with actual cases reported by HaysMed
Comparison of 2014 Estimated New Cancer Cases in United States* with Actual New Cases at HaysMed
Total Number of HaysMed Cancer Cases by Site for Last Five Years
2014 STATISTICS
|
TOTAL NUMBER OF HMC CANCER CASES BY SITE FOR LAST FIVE YEARS |
|||||
| PRIMARY SITE | 2010 | 2011 | 2012 | 2013 | 2014 |
| Bladder | 30 | 38 | 39 | 42 | 31 |
| Breast | 99 | 101 | 136 | 95 | 135 |
| Colorectal (includes anus and appendix; excludes small bowel) | 56 | 35 | 48 | 48 | 53 |
| Kidney | 15 | 17 | 20 | 12 | 23 |
| Leukemia | 18 | 10 | 14 | 13 | 19 |
| Lung & Bronchus | 54 | 59 | 60 | 60 | 60 |
| Lymphoma | 21 | 20 | 19 | 18 | 15 |
| Melanoma | 9 | 12 | 13 | 15 | 8 |
| Prostate | 80 | 70 | 64 | 48 | 63 |
| Thyroid | 10 | 16 | 13 | 17 | 4 |
| Gastrointestinal Tract/Digestive System sites, not listed above | 10 | 18 | 13 | 22 | 19 |
| Genitourinary sites, not listed above | 4 | 2 | 18 | 12 | 5 |
| Gynecologic sites | 31 | 15 | 14 | 17 | 33 |
| Head and Neck sites | 17 | 17 | 15 | 13 | 15 |
| Lymphoid neoplasms, not listed above | 27 | 21 | 25 | 16 | 17 |
| All other sites not included in above categories | 16 | 12 | 15 | 23 | 21 |
| TOTAL SITES | 497 | 463 | 526 | 471 | 521 |
2014 Cancer Cases by County
2013 Highlights
Patient Care Enhancements
• Breast Care Center re-opens in new location within HaysMed
• Full time Breast Health Navigator begins work within Breast Care Center
• Cancer Institute expansion nears completion
• Dr. Biring expressed interest in starting a Lung Cancer Screening Program @ HaysMed
• Conference call with KUMC group held
• Work begins on “home-grown” Survivorship Care Planning program with IT
• HaysMed/Debakey Heart Expansion opens
Accreditation Changes
• Medical Oncology department applies for American Society of Clinical Oncology
Quality Oncology Practice Initiative (QOPI) Certification
• Phase 1 complete
• Radiation Oncology department applies for American College of Radiation Oncology
(ACRO) Accreditation
Partnerships
• Continued partnership with the Midwest Cancer Alliance (MCA) at the University of Kansas
Medical Center, which continues to enrich our program by providing professional education
and access to clinical research trials and studies
Community Education, Screenings, and Activities
• Staff attends annual MCA Meeting. Dr. January Fields presents on Palliative Care.
• Annual Spring Cancer Symposium held @ HaysMed
• Monthly Programs: “Look Good, Feel Better”, Cancer Support Groups
• Center for Health Improvement programs: “Healing in Motion”, Lymphedema Therapy
• American Cancer Society Programs: wig bank, transportation assistance, Relay for Life,
personal health managers
• Public skin screening held @ Hays Larks baseball game
• Pink Flamingo events to promote Breast Cancer Awareness during October
2013 Stats
Inpatient Oncology
The Inpatient Oncology Unit had 329 admissions during 2013 which resulted in 1,555 patient days. The average length of stay was 4.7 days. Of the 329 admissions, 44 % were males and 56 % were females. Patient admissions included but were not limited to treatment for disease management, pain control, radiation implant management, and chemotherapy administration. Patients with leukemia (9%) and lung and respiratory cancer (9%) were the largest single diagnosis groups. Other significant diagnoses included lymphoma (7%), breast (6%), colon and rectal (6%), skin and soft tissue (4%), and thyroid (4%). Liver, stomach, esophagus, kidney and pancreatic cancers made up 7%. Six percent of the patients were treated for prostate, ovarian, urinary, and other reproductive and genital diseases. Bone cancer and brain cancer each made up 1% of the patients and the remaining 40% of admissions were for other, non-specific diagnoses including blood, benign, and unrelated diagnoses.
Medical Oncology
During 2013, there were a total of 10910 patient visits (39% males and 61% females); this number includes those patients seen by the providers in clinic visits. There were 46 patients seen for colon cancer (61% males, 39% females); 111 patients seen for lung cancer (45% males, 55% females); 429 patients for breast cancer (0% males, 100% females); 34 patients for prostate cancer (100% males); 95 patients for lymphoma (57% males, 43% females); and 1551 patients for other diagnoses (43% males, 57% females).
Radiation Oncology
In 2013, 188 patients were treated; 153 were new patients and 35 had previously been treated. There were an additional 43 patients seen for consultation only. 201 total courses of radiation therapy were delivered. There were 89 (47%) males and 99 (53%) females who received treatments. 62 women (33% of patients for the year) were treated for breast cancer, 24 (13%) men were treated for prostate cancer, 25 (13%) patients were treated for lung cancer, 16 (9%) patients were treated for skin cancer, and 10 (5%) patients were treated for colo/rectal cancer. 322 (phone 277, onsite 45) follow-up visits occurred.
2013 Comparison of Major Site Distributions Reported by HaysMed for last Five Years
Comparison of 2013 Major Site Distributions of National/State Estimations* with actual cases reported by HaysMed
Comparison of 2013 Estimated New Cancer Cases in United States* with Actual New Cases at HaysMed
Total Number of HaysMed Cancer Cases by Site for Last Five Years
TOTAL NUMBER OF HMC CANCER CASES BY SITE FOR LAST FIVE YEARS |
|||||
| PRIMARY SITE |
2009 |
2010 |
2011 |
2012 |
2013 |
| Bladder |
28 |
30 |
38 |
39 |
42 |
| Breast |
96 |
99 |
101 |
136 |
95 |
| Colorectal (includes anus and appendix; excludes small bowel) |
44 |
56 |
35 |
48 |
48 |
| Kidney |
13 |
15 |
17 |
20 |
12 |
| Leukemia |
11 |
18 |
10 |
14 |
13 |
| Lung & Bronchus |
66 |
54 |
59 |
60 |
60 |
| Lymphoma |
9 |
21 |
20 |
19 |
18 |
| Melanoma |
6 |
9 |
12 |
13 |
15 |
| Prostate |
48 |
80 |
70 |
64 |
48 |
| Thyroid |
19 |
10 |
16 |
13 |
17 |
| Gastrointestinal Tract/Digestive System sites, not listed above |
5 |
10 |
18 |
13 |
22 |
| Genitourinary sites, not listed above |
3 |
4 |
2 |
18 |
12 |
| Gynecologic sites |
16 |
31 |
15 |
14 |
17 |
| Head and Neck sites |
20 |
17 |
17 |
15 |
13 |
| Lymphoid neoplasms, not listed above |
23 |
27 |
21 |
25 |
16 |
| All other sites not included in above categories |
25 |
16 |
12 |
15 |
23 |
| TOTAL SITES |
432 |
497 |
463 |
526 |
471 |
2013 Cancer Cases by County
2012 Highlights
Patient Care Enhancements
• Expansion of Cancer Institute and remodel of Breast Care Center begins
• Full time Social Worker position approved and filled
• Medical Oncology Outreach Clinic established in Larned
• Task force created to develop a Survivorship care plan for each patient completing treatment
• Decision made to post Annual Report information on HaysMed website
• HPV Gardasil Vaccine information distributed to HaysMed Medical Staff
• Full implementation of Eclipse treatment planning system in Radiation Oncology
• The Cancer Institute was featured in Health Matters in the Hays Daily News
Milestones/Celebrations
• Former HaysMed physician Dr. Afaq Zaman Khan presented a poster at the 22nd World
Congress of the International Association of Surgoens, Gastroenterologists and Oncologists
(IASGO 2012) based on a rare esophageal cancer case treated by several physicians
at HaysMed.
The poster was submitted prior to his departure from HaysMed.
Accreditation Changes
• Cancer committee makes the voluntary decision to withdraw from the American College of
Surgeons Commission on Cancer Accreditation Program citing new standards no longer
pertinent to the focus of our cancer program
• New Cancer Program Standards developed, presented, and accepted by Cancer Committee
• Medical Oncology and Radiation Oncology begin to pursue options for specialized accreditations
Partnerships
• Continued partnership with the Midwest Cancer Alliance at the University of Kansas Medical
Center, which continues to enrich our program by providing professional education and access
to clinical research trials and studies
Enhancements
• Staff attends annual MCA meeting
• 1st Annual Spring Cancer Symposium held @ HaysMed Community Education, Screenings, and
Activities
• Monthly programs: “Look Good, Feel Better”, Cancer Support Groups
• Center for Health Improvement programs: “Healing in Motion”, Lymphedema Therapy
• American Cancer Society Programs: wig bank, transportation assistance, Relay for Life,
personal health managers
• Public skin cancer screening held at Hays Larks baseball game
• Exercise is Medicine Campaign continues at HaysMed
• Pink Flamingo events to promote Breast Cancer awareness during October
• MCA Cancer Transitions ITV program held to help cancer survivors transition from active
treatment to post-treatment care
2012 Stats
Inpatient Oncology
The Inpatient Oncology Unit had 339 admissions during 2012 which resulted in 1,636 patient days. The average length of stay was 4.8 days. Of the 339 admissions, 43 % were males and 57 % were females. Patient admissions included but were not limited to treatment for disease management, pain control, radiation implant management, and chemotherapy administration. Patients with breast (8%) were the largest single diagnosis group. Other significant diagnoses included lung and respiratory cancer (6%), leukemia (2%), bone (5%), lymphoma (4%), skin (3%), and brain (4%). Colon, peritoneum, stomach, liver, esophagus, kidney and pancreatic cancers made up 7%. Seven percent of the patients were treated for prostate and other reproductive and genital diseases. Thyroid cancer made up 2% of the patients and the remaining 52% of admissions were for other, non-specific diagnoses including blood, benign, and unrelated diagnoses.
Medical Oncology
During 2012 there were a total of 10,026 patient visits (38% male and 62% female); this number includes those patients seen by the physicians in clinic visits. There were 42 patients seen for colon cancer (57% male, 43% female); 123 patients seen for lung cancer (54% male, 46% female); 423 patients seen for breast cancer (0% male, 100% female); 28 male patients seen for prostate cancer; 93 patients seen for lymphoma (51% male, 49% female); and 1596 patients seen for other diagnoses (42% male, 58% female).
Radiation Oncology
In 2012, 209 patients were treated; 172 were new patients and 37 had previously been treated. There were an additional 30 patients seen for consultation only. 236 total courses of radiation therapy were delivered. There were 103 (49%) males and 106 (51%) females who received treatments. 47 women (22.5% of patients for the year) were treated for breast cancer, 32 (15.3%) men were treated for prostate cancer, 38 (18.2%) patients were treated for lung cancer, 14 (6.7%) patients were treated for skin cancer, and 10 (4.8%) patients were treated for colo-rectal cancer. 276 follow-up visits occurred.
2012 Comparison of Major Site Distributions Reported by HaysMed for last Five Years
Comparison of 2012 Major Site Distributions of National/State Estimations* with actual cases reported by HaysMed
Comparison of 2012 Estimated New Cancer Cases in United States* with Actual New Cases at HaysMed
Total Number of HaysMed Cancer Cases by Site for Last Five Years
TOTAL NUMBER OF HMC CANCER CASES BY SITE FOR LAST FIVE YEARS |
|||||
| PRIMARY SITE |
2008 |
2009 |
2010 |
2011 |
2012 |
| Bladder |
38 |
28 |
30 |
38 |
39 |
| Breast |
74 |
96 |
99 |
101 |
136 |
| Colorectal (includes anus and appendix; excludes small bowel) |
38 |
44 |
56 |
35 |
48 |
| Kidney |
16 |
13 |
15 |
17 |
20 |
| Leukemia |
5 |
11 |
18 |
10 |
14 |
| Lung & Bronchus |
59 |
66 |
54 |
59 |
60 |
| Lymphoma |
16 |
9 |
21 |
20 |
19 |
| Melanoma |
4 |
6 |
9 |
12 |
13 |
| Prostate |
112 |
48 |
80 |
70 |
64 |
| Thyroid |
20 |
19 |
10 |
16 |
13 |
| Gastrointestinal Tract/Digestive System sites, not listed above |
13 |
5 |
10 |
18 |
13 |
| Genitourinary sites, not listed above |
6 |
3 |
4 |
2 |
18 |
| Gynecologic sites |
23 |
16 |
31 |
15 |
14 |
| Head and Neck sites |
17 |
20 |
17 |
17 |
15 |
| Lymphoid neoplasms, not listed above |
27 |
23 |
27 |
21 |
25 |
| All other sites not included in above categories |
22 |
25 |
16 |
12 |
15 |
| TOTAL SITES |
490 |
432 |
497 |
463 |
526 |
2012 Cancer Cases by County
2011 Highlights
Patient Care Enhancements
• Medical Oncology outreach clinics established in Colby and Norton
• Purchase and installation of new Eclipse® treatment planning computer system
and diode system in radiation oncology
• Near 100% compliance for all chemo orders being entered electronically in
Meditech Oncology Module
• Common Scheduler created to inform patients of all appointments at HaysMed
• Plans for remodel of Dreiling Schmidt Cancer Institute and Breast Care Center begins
• Overhead lifts installed in patient rooms
• Bathroom remodels begin hospital-wide
Milestones/Celebrations
• Breast Care Center officially opens May 23rd
• Susan G. Komen Grant awarded for Patient Navigation to the Breast Care Center
Partnerships
• Continued partnership with the Midwest Cancer Alliance at the University of Kansas
Medical Center, which continues to enrich our program by providing professional education
and access to clinical research trials and studies.
Education
• Sizzlin’ Summer 2011-Cancer Updates held July 13th and 14th
• Staff attends annual MCA meeting
Community Education, Screening, and Activities
• Early Detection and Prevention Cancer Modules were presented during 2 of the weekly
weigh-ins for the Pound Plunge. Types of cancers highlighted were Breast, Skin, Lung,
and Colorectal
• Monthly programs: “Look Good, Feel Better”, Cancer Support Groups
• Center for Health Improvement programs: “Healing in Motion”, Lymphedema Therapy
• American Cancer Society Programs: wig bank, transportation assistance, Relay for Life,
personal health managers
• Colorectal Cancer awareness program presented in March in partnership with Southwind
Surgical, including Bottoms Up 5K walk/run
• Public skin cancer screening held at Hays Larks baseball game
• Exercise is Medicine Campaign begins at HaysMed
• Pink Flamingo events to promote Breast Cancer awareness during October
2011 Stats
Inpatient Oncology
The Inpatient Oncology Unit had 334 admissions during 2011 which resulted in 1,762 patient days. The average length of stay was 5.3 days. Of the 334 admissions, 48% were males and 52% were females. Patient admissions included but were not limited to treatment for disease management, pain control, radiation implant management, and chemotherapy administration. Patients with lung cancer (9%) were the largest single diagnosis group. Other significant diagnoses included breast (4%), leukemia (4%), bone (5%), lymphoma (7%), skin (3%), and brain (3%). Colon, peritoneum, stomach, liver, esophagus, kidney and pancreatic cancers made up 18%. Six percent of the patients were treated for prostate and other reproductive and genital diseases. Thyroid cancer made up 2% of the patients and the remaining 39% of admissions were for other, non-specific diagnoses.
Medical Oncology
During 2011 there were a total of 10805 patient visits (37% males and 63% females); this number includes those patients seen by the physicians in clinic visits. There were 44 patients seen for colon cancer (48% males, 52% females); 111 patients seen for lung cancer (52% males, 48% females); 427 patients for breast cancer (0% males, 100% females); 21 patients for prostate cancer (100% males); 103 Patients for lymphoma (52% males, 48% females); and 1744 patients for other diagnoses (33% males, 67% females).
Radiation Oncology
In 2011, 205 patients were treated; 173 were new patients and 32 had previously been treated. There were an additional 40 patients seen for consultation only. 225 total courses of radiation therapy were delivered. There were 99 (48%) males and 106 (52%) females who received treatments. 48 women (23.4% of patients for the year) were treated for breast cancer, 33 (16.1%) men were treated for prostate cancer, 34 (16.6%) patients were treated for lung cancer, 22 (10.7%) patients were treated for skin cancer, and 11 (5.4%) patients were treated for colo/rectal cancer. 296 follow-up visits occurred.
2011 Comparison of Major Site Distributions Reported by HaysMed for last Five Years
Comparison of 2011 Major Site Distributions of National/State Estimations* with actual cases reported by HaysMed
Comparison of 2011 Estimated New Cancer Cases in United States* with Actual New Cases at HaysMed
Total Number of HaysMed Cancer Cases by Site for Last Five Years
TOTAL NUMBER OF HMC CANCER CASES BY SITE FOR LAST FIVE YEARS |
|||||
| PRIMARY SITE |
2007 |
2008 |
2009 |
2010 |
2011 |
| Bladder |
35 |
38 |
28 |
30 |
38 |
| Breast |
93 |
74 |
96 |
99 |
101 |
| Colorectal (includes anus and appendix; excludes small bowel) |
33 |
38 |
44 |
56 |
35 |
| Kidney |
15 |
16 |
13 |
15 |
17 |
| Leukemia |
6 |
5 |
11 |
18 |
10 |
| Lung & Bronchus |
43 |
59 |
66 |
54 |
59 |
| Lymphoma |
13 |
16 |
9 |
21 |
20 |
| Melanoma |
6 |
4 |
6 |
9 |
12 |
| Prostate |
93 |
112 |
48 |
80 |
70 |
| Thyroid |
7 |
20 |
19 |
10 |
16 |
| Gastrointestinal Tract/Digestive System sites, not listed above |
12 |
13 |
5 |
10 |
18 |
| Genitourinary sites, not listed above |
7 |
6 |
3 |
4 |
2 |
| Gynecologic sites |
20 |
23 |
16 |
31 |
15 |
| Head and Neck sites |
16 |
17 |
20 |
17 |
17 |
| Lymphoid neoplasms, not listed above |
21 |
27 |
23 |
27 |
21 |
| All other sites not included in above categories |
18 |
22 |
25 |
16 |
12 |
| TOTAL SITES |
438 |
490 |
432 |
497 |
463 |
2011 Cancer Cases by County
